J Korean Med Assoc Search

CLOSE


J Korean Med Assoc > Volume 63(1); 2020 > Article
Journal of the Korean Medical Association 2020;63(1):14-19.
Published online January 17, 2020.
DOI: https://doi.org/10.5124/jkma.2020.63.1.14   
Kidney disease in patients with chronic liver disease
Jae Hyun Chang
Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea. jhchang@gilhospital.com
Abstract
The kidneys are closely connected with several organs, including the liver, and can therefore be negatively affected when the liver is damaged. The most common cause of chronic liver disease is chronic viral hepatitis, resulting from either a hepatitis B virus (HBV) or a hepatitis C virus (HCV). Chronic viral hepatitis often progresses to cirrhosis and hepatocellular carcinoma. However, it can also lead to viral-associated glomerulopathies that can cause chronic kidney disease (CKD), which can then progress to end stage renal disease (ESRD). Additionally, patients with ESRD on hemodialysis are at risk for viral infections because HBV and HCV are hematogenously transmitted. Recently, treatments with oral nucleoside/nucleotide analogues and direct-acting antivirals have yielded excellent results in HBV- and HCV-infected patients with CKD. As a result, a new paradigm for the treatment of chronic viral infections in CKD patients has emerged. This review discusses viral-associated glomerulopathies, antiviral treatments of HBV and HCV infections in patients with CKD, and prevention strategies for the transmission of HBV and HCV in patients with ESRD.
Key Words: Chronic disease, Liver diseases, Hepatitis B virus, Hepatitis C virus, Kidney diseases
 


ABOUT
ARTICLE CATEGORY

Browse all articles >

ARCHIVES
FOR CONTRIBUTORS
Editorial Office
Samgu B/D 7F, 40 Cheongpa-ro, Youngsan-gu, Seoul 04373, Korea
Tel: +82-1566-2844    Fax: +82-2-792-5208    E-mail: jkmamaster@gmail.com                

Copyright © 2022 by Korean Medical Association.

Developed in M2PI

Close layer
prev next